関連文献

Different renoprotective effects of luseogliflozin depend on the renal function at the baseline in patients with type 2 diabetes: A retrospective study during 12 months before and after initiation.

PLoS One. 2021 doi: 10.1371/journal.pone.0248577.PubMed

Renoprotective effects of canagliflozin, a sodium glucose cotransporter 2 inhibitor, in type 2 diabetes patients with chronic kidney disease: A randomized open-label prospective trial.

Diab Vasc Dis Res. 2018 doi: 10.1177/1479164118782872. Epub 2018 Jun 20.PubMed

Topiroxostat-A Safer Uricostatic Drug with Enhanced Renal Protection: A Narrative Review.

J Assoc Physicians India. 2024doi: 10.59556/japi.72.0724.PubMed

Urinary liver-type fatty acid binding protein is a biomarker reflecting renal damage and the ameliorative effect of drugs at an early stage of histone-induced acute kidney injury.

Nephrology (Carlton). 2023doi: 10.1111/nep.14254.PubMed

Markers of Kidney Tubular Function Deteriorate While Those of Kidney Tubule Health Improve in Primary Aldosteronism After Targeted Treatments.

J Am Heart Assoc. 2023PubMed

Association of urinary liver-type fatty acid-binding protein with renal functions and antihyperglycemic drug use in type 2 diabetic nephropathy patients.

Int Urol Nephrol. 2023PubMed

Tubular Injury Causing Protracted Glycosuria Following Withdrawal of a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor: A Possible Role in the Development of Protracted Hypoglycemia and Ketoacidosis.

Tohoku J Exp Med. 2021PubMed

Effect of Dipeptidyl Peptidase-4 (DPP-4) Inhibition on Biomarkers of Kidney Injury and Vascular Calcification in Diabetic Kidney Disease: A Randomized Controlled Trial.

J Diabetes Res. 2021doi: 10.1155/2021/7382620. PubMed

Effect of linagliptin on oxidative stress markers in patients with type 2 diabetes: a pilot study.

Diabetol Int. 2018PubMed

Effect of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on cisplatin-induced nephrotoxicity in mice.

Naunyn Schmiedebergs Arch Pharmacol. 2018PubMed